US 9012508
Administration of intravenous ibuprofen
granted A61KA61K31/192A61K31/485
Quick answer
US patent 9012508 (Administration of intravenous ibuprofen) held by Cumberland Pharmaceuticals Inc. expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cumberland Pharmaceuticals Inc.
- Grant date
- Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/192, A61K31/485, A61K9/0019, A61K9/08